Our Senior Team

Dennis Crandall

Dennis Crandall

Managing Director New York

Biography

Dennis Crandall is a Managing Director at Moelis & Company, where he specializes in advising clients in the life sciences and outsourced pharmaceutical services sectors (e.g., SMOs, CROs, technology-enabled services, commercialization, and CDMOs). He has extensive experience in healthcare investment banking, with expertise in executing a broad range of transactions for healthcare corporations and financial sponsors.

Prior to joining Moelis & Company, Dennis was a Managing Director in the Healthcare Investment Banking Group at Morgan Stanley. Before that, he worked on the M&A team at UBS Investment Bank and held various advisory roles at KPMG. He started his finance career at Jacobsen Capital Management. Dennis holds a B.S. in Management from Brigham Young University and an M.B.A. from the Kellogg School of Management at Northwestern University.

T: +1 212 883 3525

Our Strategic Alliances

MA Moelis Australia

Moelis & Company provides investment banking advice in Australia through our strategic alliance with MA Moelis Australia, the Corporate Advisory and Equities division of MA Financial Group, an Australian Stock Exchange (ASX) listed firm. MA Moelis Australia provides financial advice for clients across M&A and strategic advisory, equity and debt capital markets, capital structure advisory, equities research and trading.

Learn more about MA Moelis Australia here.

Learn more about MA Financial Group here.

Alfaro, Dávila y Scherer, S.C.

Moelis & Company has a strategic alliance with Alfaro, Dávila y Scherer, S.C. (“ADS”), the leading independent strategic and financial advisory firm in Mexico, to provide advisory services to our global client base with a focus on Mexican cross-border transactions. Founded in 2003, ADS advises a select number of clients on strategic mergers, acquisitions, divestitures, capital raising and financial restructurings.

Learn more about ADS team here.